3.0.0 2103 2022-11-01T13:50:41Z 2022-11-01T13:50:41Z Senate S 2019-07-11 116 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2019-07-11T19:09:04Z 116 6155 HR 2020-03-09 Referred to the House Committee on Energy and Commerce. Related bill CRS 2019-07-11 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809) IntroReferral 2019-07-11 Introduced in Senate IntroReferral 10000 9 Library of Congress D000563 Sen. Durbin, Richard J. [D-IL] Richard Durbin D IL J. N C001096 Sen. Cramer, Kevin [R-ND] Kevin Cramer R ND 2019-07-11 True S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN 2019-07-11 True H001079 Sen. Hyde-Smith, Cindy [R-MS] Cindy Hyde-Smith R MS 2019-07-23 False C001047 Sen. Capito, Shelley Moore [R-WV] Shelley Capito R WV Moore 2019-07-25 False R000615 Sen. Romney, Mitt [R-UT] Mitt Romney R UT 2019-07-30 False S001181 Sen. Shaheen, Jeanne [D-NH] Jeanne Shaheen D NH 2019-07-30 False J000300 Sen. Jones, Doug [D-AL] Doug Jones D AL 2019-07-31 False M001153 Sen. Murkowski, Lisa [R-AK] Lisa Murkowski R AK 2019-09-11 False B000944 Sen. Brown, Sherrod [D-OH] Sherrod Brown D OH 2019-09-11 False M001176 Sen. Merkley, Jeff [D-OR] Jeff Merkley D OR 2019-09-17 False B001310 Sen. Braun, Mike [R-IN] Mike Braun R IN 2019-09-17 False P000595 Sen. Peters, Gary C. [D-MI] Gary Peters D MI 2019-09-25 False W000437 Sen. Wicker, Roger F. [R-MS] Roger Wicker R MS F. 2019-09-25 False H001061 Sen. Hoeven, John [R-ND] John Hoeven R ND 2019-10-29 False S001191 Sen. Sinema, Kyrsten [D-AZ] Kyrsten Sinema D AZ 2019-11-21 False G000562 Sen. Gardner, Cory [R-CO] Cory Gardner R CO 2019-12-17 False Health Digestive and metabolic diseases Drug safety, medical device, and laboratory regulation Drug therapy Licensing and registrations Prescription drugs Health

00 2019-07-11 Introduced in Senate 2020-08-04T14:50:31Z Affordable Insulin Approvals Now Act

This bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.

]]>

Display Title Short Title(s) as Introduced Introduced in Senate IS Official Title as Introduced Introduced in Senate IS Introduced in Senate 2019-07-11T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s2103is/xml/BILLS-116s2103is.xml 2019-07-11 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.